Emerging Biopharma

bet poker chips
Biotech

ARPA-H goes all in on in vivo cell therapy

One of the grant winners is a newly emerged biotech called ImmunoVec, which debuted with up to $40.7 million in funding from ARPA-H.
Darren Incorvaia Oct 8, 2025 4:04pm
human brain abstract art

Nilo launches with $101M and mission to harness neural circuits

Oct 8, 2025 9:55am
Aerska team

Irish biotech launches with $21M to shuttle RNAi meds to brain

Oct 1, 2025 10:34am
Fish oil pills sitting in a fish-shaped dish

Fatty acid eye injections restore vision in old mice

Sep 26, 2025 2:10pm
Gateway Lab San Diego

Eli Lilly opens latest incubator site in San Diego

Sep 26, 2025 9:55am
new york stock exchange

New York Stock Exchange honors Fierce 15 winners

Sep 23, 2025 10:16am
More News

Fierce Biotech's 2025 Fierce 15

Sep 22, 2025 8:00am

US VC launches another biotech with China-licensed asset

Sep 17, 2025 10:30am

Pfizer vet takes CEO post at new, phase 3-ready biotech

Sep 9, 2025 10:03am

Corsera launches with $50M for predictive AI tool, RNAi asset

Sep 2, 2025 6:30am